Questions have been raised about how Australia ensures the quality of its imported medicines is up to standard after a major pharmaceutical company was warned over lapses in contamination control and manufacturing practices.
The US Food and Drug Administration (FDA) has written a letter to multinational company Sun Pharmaceuticals accusing it of "significant" manufacturing violations at its plant in Halol, India.
